The role of CD44 and matrix metalloproteinase–9 expression in predicting neck metastasis of supraglottic laryngeal carcinoma

This publication has 24 references indexed in Scilit:

• Can biomarkers play a role in the decision about treatment of the clinically negative neck in patients with head and neck cancer?
  Head & Neck, 2008
• Is routine bilateral neck dissection absolutely necessary in the management of N0 neck in patients with supraglottic carcinoma?
  European Archives of Oto-Rhino-Laryngology, 2007
• Matrix metalloproteases in head and neck cancer
  Head & Neck, 2006
• Overexpression of MMP‐2 in laryngeal squamous cell carcinoma: A potential indicator for poor prognosis
  Otolaryngology–Head and Neck Surgery, 2005
• Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma
  Oral Oncology, 2005
• Expression of Matrix Metalloproteinases in Supraglottic Carcinoma and Its Clinical Implication for Estimating Lymph Node Metastases
  The Laryngoscope, 2004
• Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer
  Auris Nasus Larynx, 2004
• Decreased CD44H expression in early-stage tongue carcinoma associates with late nodal metastases following interstitial brachytherapy
  Head & Neck, 2000
• Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions
  Proteins: Structure, Function, and Bioinformatics, 2000
• Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion
  Genes & Development, 1999